Tristel has published interim results for the 6-months to December 2024, reporting revenues of £22.6m, up 8% YoY (9% CER), driven by volume of 6% and price of 2%. Revenue growth driven by Tristel Medical device revenues, grew 8% to £19.7m. Tristel expanded its strong margins during the period, delivering gross margin of 82% (1H24: 81%) and adjusted EBITDA margin of 28% (1H24: 26%). Adjusted profit before tax grew 19% to £4.9m. The company has proposed an 8% increase in DPS to 5.68p and closed th ....
